OncologyTube Professional - Patients Click Here
29,897 video views
Loading........
Description: In this 10-minute video, Dr. Martin Edelman, professor of medicine at the University of Maryland School of Medicine and director of Solid Tumor Oncology at the University of Maryland Greenebaum Cancer...
10:12
In this 10-minute video, Dr. Martin Edelman, professor of medicine at the University of Maryland School of Medicine and director of Solid Tumor Oncology at the University of Maryland Greenebaum Cancer Center, comments on the results of a study published in The Lancet, which found that aspirin was successful in preventing the occurrence of solid tum...
by:umgcc | 3537 views
03:08
SIRT is a non-surgical outpatient therapy that uses radioactive microspheres, called SIR-Spheres, to deliver radiation directly to the site of the liver tumors. This unique, targeted therapy spares healthy tissue while delivering up to 40 times more radiation to the liver tumors than would be possible using conventional radiotherapy. In this video...
by:umgcc | 3485 views
05:26
Experts at the University of Maryland Medical Center are using Irreversible Electroporation, one of the newest techniques available for treating hard-to-reach soft tissue tumors. The process, known as IRE, offers another option for patients who have cancerous tumors that are close to blood vessels, ...
by:umgcc | 3856 views
02:16
A multicenter clinical trial led by Dr. Saranya Chumsri, assistant professor of Medicine at the University of Maryland School of Medicine and oncologist at the University of Maryland Marlene and Stewart Greenebaum Cancer Center, will evaluate a new approach to treat triple-negative breast cancer, an often-aggressiv​e type of cancer that is more comm...
by:umgcc | 3580 views
04:23
In this four-minute video, Dr. H. Richard Alexander, professor of surgery at the University of Maryland School of Medicine and surgical oncologist at the University of Maryland Greenebaum Cancer Center, explains his research laboratory's recent discovery of some important cellular pathways and proteins that affect the growth of tumor cells in malig...
by:umgcc | 3592 views
03:09
The University of Maryland Greenebaum Cancer Center has opened a new Phase I/IIa clinical trial for multiple myeloma. The trial is designed to investigate the safety, bioactivity and anti-tumor effect of infusion of patients' own T cells that have been genetically modified to express a high affinity T cell receptor (TCR) specific for a type of tumo...
by:umgcc | 3175 views
05:05
Triple negative breast cancer is an aggressive sub-type of breast cancer in which the tumor cells lack all of the conventional drug targets for breast cancer, such as estrogen, progesterone and HER2 receptors. Because the tumor cells lack these receptors, treatments such as hormone therapy, like tamoxifen and aromatase inhibitors, or drugs that tar...
by:umgcc | 2927 views
04:56
Dr. Stuart Martin explains his lab's discovery of microtentacles on circulating tumor cells, and their possible role in tumor metastasis, in this 5-minute video. Targeting microtentacles with drugs to prevent them from attaching to blood vessel walls in distant tissues of the body, and thereby preve...
by:umgcc | 3055 views
01:39
Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer have found that head and neck cancer patients who test positive for the human papillomavirus (HPV) have much better survival rates than patients who don’t have the virus, according to a new study in the journal Cancer Pr...
by:umgcc | 2690 views

About umgcc


Links
Channel Url: